LIVE
BREAKING LIVE

The news moving markets, right now

From international newswires in real time. For every story the News Impact AI agent estimates the market impact and flags the assets to watch, with the story’s impact on each: positive, negative or neutral.

STORIES TODAY
95
via globenewswire.comBusiness & Companies

Valneva announces positive Phase 2 results for tetravalent Shigella vaccine candidate S4V2

FROM THE WIRE · GLOBENEWSWIRE.COM

Data from infant immunogenicity and safety trial, and controlled human infection model (CHIM) trial, demonstrate favorable safety profile with encouraging immunogenicity and efficacy signals

Read at the source ↗
MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishPositive Phase 2 data for a vaccine candidate can support the shares of a small biotech.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
  1. 01Data come from an infant immunogenicity and safety trial and a controlled human infection model trial.
  2. 02The trials demonstrate a favorable safety profile.
  3. 03Encouraging immunogenicity and efficacy signals were observed.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets

ALL BREAKING TODAY

Breaking live stories come from third-party newswires via feed; headline and summary belong to the stated source. Impact analysis: UCapital AI · News Impact.

AI use policy. UCapital AI supports the newsroom with news analysis, summaries, market reactions, translations and the generation of cards and charts. AI-generated or AI-assisted content is labelled in the byline (AI Desk, a named AI profile marked «AI», or joint byline) and is reviewed by editors before publication. News received via API feeds from third-party providers is attributed to the original source. AI can make mistakes: report any inaccuracies to the newsroom. Users’ personal data is not used to train the models.